Dear Reader,

If this keeps happening, a lot of people are going to get very rich.

I’m talking about this past January when our Money Map research staff turned up an amazing little gem of an opportunity that some of the wealthiest and most successful drug industry experts had been plowing millions into.

We soon found out why.

The company was working on a very important pain medication for shingles… and all signs were the FDA was getting ready to approve the drug in mere days.

Yet curiously, very few regular investors were buying into the stock…

This was clearly one of those “lets-keep-this-among-friends” situations that billion-dollar hedge fund managers who work the small stocks market love!

We crashed the party anyway… by sending out an urgent briefing on the company in mid-January to a small group of our lifetime subscribers.

We said “buy this stock now” while it’s still in the $5 to $6 range – and look for it to surge right around the end of the month.

How sure were we?

So sure that we did something we’ve never done:

We offered to write a check for $2,475 to help cover any starting stake in the company!

Long story short, word came down from the FDA on January 31st: APPROVED!

Within three days the stock soared to $10.40. Those who followed our research had an opportunity to pocket a very fast 93% in a matter of days.

As you can imagine we got quite a few emails in, many of them like this one from subscriber Michael Mack:

“All I can say is WOW! As of today (the stock) is up 60% and rising. Thank you so much, looking forward to a great year with the (Passport) Club.”

And we don’t think that’s nearly the end of it. Once this drug gets in the hands of doctors – and as its burgeoning drug pipeline matures – it could be a $40 to $50 stock within a year or two.

But here’s why I’m talking to you today…

Another Opportunity Has Just Come Up!

While researching this opportunity, we believe we identified a highly predictive “stock accumulation pattern” that can tell us which little companies these successful funds think are on the verge of breakthrough gains.

More specifically, we’ve found another tiny little company many of these same players are rallying around… and for very good reason.

It’s a company that very well could be on the verge of one of the biggest drug breakthroughs since Viagra – and given the demand for this kind of treatment, the FDA would like nothing better than to approve it before the year is out.

The stock is trading cheap right now – right around $2.

What’s more, there are two very important “catalyst dates” coming up that should jolt the stock higher on each occasion – the first one in by Summer and the second in October. (I’ll tell you more about it in a moment.)

You want to be in at today’s price when that happens.

That’s because our research suggests this little stock could (and should) be trading at over $5 within the year – a better than 150% gain from where it trades now.

But that’s just the beginning…

Should this little company’s treatment keep getting great results through Phase 3 testing and make it to market in the next year or two…

This company could be the lone player in what’s estimated to be a $2 billion market… and watch its share price rocket to $148 or more in the next five years alone!

Consider that for a moment.

If you were to invest a modest $25,000 in 12,500 shares today…

You could retire early with $1,850,000 or more in gains!

See why we’ve dubbed this “The Retirement Stock”?

Let Us “Cover Your Play”

In fact, we’re so confident that this opportunity has the very real potential to generate millions in new wealth for a small group of readers, that we’re going to repeat what we did for a small group of our best readers this past January…

We’re going to “cover your play,” as it were… by sending you money upfront in the form of a check from Money Map Press as a way to get into the position.

Now, as far as I know, no publisher but us has ever done this before – offered to send you money to cover a nice starting stake you might take in a stock.

And just to be clear, you’re under no obligation to buy the stock with the money we send you. You can use it for anything you like…

But here’s the thing.

We’re so confident this company’s drug will one day soon be “the next Viagra,” that we’re happy to assume some of the risk of you owning it… by sending you $2,475 up front – enough to easily pay for 1,200 shares or more.

Here’s how the whole thing will work – beginning with details on the little company the Money Map research team is so excited about.

By Far, The Most Explosive Sector of the Market

Few things can make you richer faster than a little-known company with a drug that’s sure to be a major player in a billion-dollar market.

Our initial success with the company we uncovered a few months ago is proof. We saw the potential for near 100% gains come very quickly – and the drug hasn’t even reached the market yet!

And there are plenty of other examples. For instance,

	When Pharmacyclics had early trial success with its tumor drug last year, the stock gained over 1,380% in 14 months…
	When Dynavax came up with an effective H1N1 flu vaccine, its stock gained 1,600% in 10 months… including a one-day gain of 569%…
	When Dendreon’s drug Provenge was shown to boost survival rates in prostate cancer cases, the company’s stock better than doubled in a day… and shot 2,023% higher in less than a year.

A mere $10,000 in any one of them could have handed you cash gains ranging from $138,000 to $202,000.

But I know what you’re thinking…

Anyone can rattle off successes after they’ve happened…

As an investor, you want to be “early in” on the next groundbreaking stock. How do you do that? One surefire way…

It’s like when the whistleblower “Deep Throat” told Watergate reporter Bob Woodward that the best way to know what’s really going on is to:

Just like with the company we found earlier this year, some of the wealthiest and most successful drug industry experts have been plowing millions into this tiny little company.

Of course the big names like Blackrock, State Street and Vanguard are all in.

But one investor – a medical doctor and co-founder of a investment firm that specializes in medical start-ups – interests us the most.

With a nearly 5% share stake he’s not only the largest individual shareholder already – he recently upped his stake in the company by over 28%.

Of course we can’t claim to know his motives for padding his share ownership by millions. But the timing of his buying spree does seem somewhat telling.

The company had recently reported stellar Phase 2 Clinical trial results – and announced that enrollment in a pair of Phase 3 efficacy trials would both be underway by this summer.

Typically, this is the last set of tests before a drug can be approved by the FDA. And because Phase 2 trials went so smoothly, many in the industry feel the Phase 3 tests are more of a formality than anything else.

In addition, the company recently announced it had secured nearly $25 million in additional investor funding to see the Phase 3 efficacy and safety trials through to their completion.

Clearly, the company – along with its top investor – believe this drug, which is a breakthrough Viagra-like treatment for postmenopausal women suffering from sexual desire disorder – believe the chances for approval are very good.

Two things suggest they’re right.

Last June, an FDA committee stated that HSDD (Hypoactive Sexual Desire Disorder) is a significant medical condition for women. Said the company’s CEO: “This (statement) is relevant since the FDA never has approved a drug for this condition, so it’s good when the FDA or its advisors say that a product is needed here.”

Tack on the fact that Phase 2 clinical trial results showed the company’s treatment significantly increasing the number of “satisfying sexual events” by 238% in menopausal women – with no serious adverse side effects.

That latter part is absolutely crucial because safety concerns are by far the No. 1 reason most drugs that go through the FDA process fail to gain approval.

So when a drug is shown to work like a charm – and it’s safe as well – that’s when people close to the game start to take notice.

And why are they so excited about this drug in particular?

Two words: Enormous Demand.

According to consulting firm IMS Health, there were more than four million testosterone subscriptions written for women in 2009 in an attempt to treat FSD (Female Sexual Dysfunction) – and company surveys said that an overwhelming number of physicians would switch to this company’s product if it were approved by the FDA.

Plus the company’s own research found that sexual dysfunction is one of the most common complaints gynecologists hear, averaging about 37 inquiries per month.

A Journal of American Medical Association study several years ago found that 31% of women in the 18 to 59 age group experience low sexual desire – and that number jumps to 43% in the 57 to 85 age group.

Based on all the data, the company estimates that the market for FSD is somewhere in the $2 billion to $5 billion per year range…

And given this company could soon have the only FDA-approved solution on the market, revenues could be $1 billion per year or more from this one product alone according to data from pharmaceutical provider BioScrip – resulting in profits nearing $400 million!

Based on current shares outstanding in this company, that’s about $4.70 in per share earnings.

What does that mean as far as potential for the stock price goes?

Well, given drug industry price-to-earnings ratios for up and coming companies range from 21 to 45 – that could put the stock price at anywhere between $98 a share to $212…

And that’s based only on the revenues from this drug alone!

The company has a number of other very promising drugs in its aggressive pipeline as well – and I’ll tell you about a few of those in a moment. 

But here’s where you come in…

I’d like to send you a full report on this company before the expected catalysts (the first expected in the next 30 days) happen…

So you can have an opportunity to be there if and when the stock more than doubles in the weeks ahead – and to pocket the potential for 100-to-1 gains that could follow…

And maybe you’re thinking there must be a catch – which, in fact, there is.

It is simply this:

Because of the very small size of this company, we are not at liberty to divulge this recommendation with anyone beyond you and a few of your fellow Money Map readers.

Of course, sharing this with a small group has its advantages.

For one thing it allows us to make you quite an extraordinary and, we think, generous offer…

Where we can write you a check for $2,475 – money to use however you please, whether it be pay some bills… enjoy a nice weekend somewhere… or help cover a nice-sized stake you decide to take in this little company should you choose to buy it (Over 1,000 shares… likely more).

I’ll tell you how you can claim your check in a moment – and why the little company that’s caught the attention of so many Wall Street money men could make you as much as 100 times your money over the next five years.

Money Map Is Growing Fast

But first, maybe you think it’s a little unusual that we’re doing this at all – offering you money that you can use toward the cost of a stock we’re confident will be one of – if not the – biggest stock story of the year.

As I said, this is the kind of thing we can only do for our most avid and loyal readers.

In fact, you are receiving this letter because you most definitely fall into that category as a current subscriber to one or more Money Map Press publications.

And while we appreciate your business and your loyalty, what I’m proposing you do today is “give up” your current subscription…

We call this group our Money Map Passport Club.

If you’re new to Money Map Press, you may not have heard of it. Fact is, it’s extremely rare that we advertise it. We typically offer it once or twice a year at most, for a few weeks at a time.

The reason we don’t make it readily available often is we understand it’s not for everyone… and we prefer to keep this group small.

It’s for avid investors who understand that the markets are constantly undergoing “sea changes” – that the ways to make money are constantly evolving…

And that the best way to keep up with these ever-shifting opportunities is to hear and see research from all corners of the market.

If you’ve already enjoyed and profited from the advice and research you’ve seen from us – then the decision to become a Passport Club member should be a no-brainer.

All Our Research – Forever

Because for a one-time fee you receive all of our research for as long as we publish it…

That includes everything we publish now – and everything we publish in the future. (Plus more benefits and privileges we can only offer our best readers, which I’ll talk about in a minute…)

So just what is the Money Map Passport Club – and what does it entitle you to?

Let me tell you.

If you’ve been with Money Map from the beginning back in 2007, you know we’ve grown very quickly over the years.

That’s no accident. As publisher, Mike Ward makes it his daily mission to find you the kinds of investments the mainstream press either won’t (or can’t) talk about.

As a result he’s spent millions of dollars in the short time we’ve been in business… on research, on recruiting the world’s top experts, and on the technology needed to bring it all to you in real time.

In those years we’ve grown from one elite service, The Money Map Report – to 10 of the most successful advisory services you’ll find anywhere, with standard prices ranging from $99 to $4,000 per year.

You may have received letters from us inviting you to try one of them at any given time. In fact, if you were to subscribe to all the services we carry today at the regular prices, it would cost you $26,292 per year.

An Amazing Line-Up Of Services

And in our humble opinion, worth every cent – when you consider, for instance, that our Geiger Index advisory alone, at $3,900 per year, has just had a run of 34 consecutive winners in a row.

Needless to say we’ve received many e-mails from happy Geiger subscribers, including this one from Gerry Lowe:

“How pleased I was with the help I have received from Keith Fitz-Gerald. I matched up my skills with Keith’s great recommendations and profited in excess of $1.5 million. Please pass on to Keith my profound appreciation.”

But Geiger‘s just one service that’s making its share of millionaires.

MicroQuake Alert, at $2,900, delivered eight out of ten winning trades in 2010 since its launch in August. And, between April 18th and 20th of this year, subscribers locked in not one but two triple-digit gains of 157% and 108%…

We’ve enjoyed over 580% in cumulative gains from New China Trader in 2010 alone… and already this year we’ve seen several big jumps including one Chinese miner up 121%.

Our commodities service, the Global Resource Alert, closed out recommendations totaling 685% in cumulative gains in 2010… and is off to a very strong 2011 with gains of 169%, 144% and 131% as of right now.

Very recently we secured the services of arguably the most knowledgeable, respected, and connected energy expert in the world – Dr. Kent Moors.

You may have heard a presentation from Dr. Moors recently inviting you into his Energy Inner Circle ($2,999 per year).

He talks about how he’s been a long-time advisor to governments, emirs, oil companies, and global energy leaders when it comes to strategic energy matters – and all the opportunities he sees as a result.

I’ve spent many hours with Dr. Moors these past months and it’s amazing just who and how much he knows about "behind the scenes" happenings in the energy industry… new energy field discoveries… and where the coming opportunities are.

If there’s any question as to the insights this man has into the world of energy, look no further than his track record so far – up a cumulative 197% since we coaxed him to divulge his secrets back in July.

I’ll tell you more about the terrific advisory services we offer in a moment…

A Labor of Love

But before I do, you can probably tell we’re enormously proud of the work we’re doing here at Money Map Press. This has been a labor of love for us since we started up four short years ago.

The team we’ve put together – Keith Fitz-Gerald, Shah Gilani, Peter Krauth, Martin Hutchinson and, most recently, Dr. Kent Moors – are among the most knowledgeable and successful investment people in the business.

It’s because of this amazing talent – coupled with our broad scope and reach into more financial markets – that I’m 100% confident in saying:

If you were to choose and stick with just one advisory group from this day forward, I believe you would become most wealthy by choosing us.

Many Money Map readers agree already. Take a look at what some have said…

“The Alpha Bulldog Permanent Wealth portfolio has been, to say the least, an ‘enriching’ experience. I’ve had very good results with BGS, PSEC, EGO, GDX, and TBT. It took me time to trust the selections and recommendations, but the capital gains and juicy dividends have made a believer out of me. I would recommend it to anyone who needs steady income with growth, or growth with income, either way.”

– Marc Courtenay

“I just joined today and feel that I am way ahead already. You will feel the same way once you join. Start the new year off right with the Geiger Index.”
– Peter Stephens, VA

“I felt I had to email you to say how delighted and staggered I am at the additional $9,100 I have been notified I will receive on 29th June. It is by far the largest payout I have ever received for holding 400 shares of a company, and that is on top of the already received amount of $3,804.76. Picking TKG for the Permanent Wealth Portfolio was surely a masterstroke!”

– William Asprey

“Hello Dr. Moors, I just bought 1k shares of ALY and it is up over $180.00 in a very quick time. I am very impressed – you sure know how to pick them.”

– Howard Bell

“Keith, I have used the Geiger recommendations most of the time and have made money on them… success with the Geiger is what made me join the Money Map Passport Club.”

– Lon Blauvelt

“Shah, Thank you so much for the excellence you are bringing to the investment newsletter world. You don’t give hype; you give good solid ideas with an eye to big trends. I’ve subscribed to a lot of newsletters over the past few years, but I am the most excited about yours. I’ve had several options services, as well as a commodity trading service, but none gave me the feeling that I could be competent with what I’m doing. Your explanations, advice, and teaching really help to give me that sense, so I want to say a big ‘Thank you!’ Keep it up! :)”

– Clark Bickers

“I’m a new subscriber to the Capital Wave service and really appreciate the clear explanations and reasoning in Shah’s communications.”

– Suzanne Johnson

“Dr. Moors, I am a very small investor and I do appreciate your insights, self-apparent honesty, and particularly your foresight. VERY impressed!”

– Robert Strachan, CMA

“I just wanted to say, ‘Thank You!’ for your outstanding Permanent Wealth Investor service, of which I am a charter member via the Money Map Passport Club. Your Permanent Wealth Investor service is absolutely outstanding, exactly as advertised, and I couldn’t be happier that you have so honored the trust and faith I put in you.
May you live long so I can continue to prosper!”

– Mike M., Michigan

If you would like to see all the research we offer, the modest one-time fee you’ll pay to join the Passport Club is by far the best way to go.

As a Passport Club member, you get every resource we publish. Not just for a year… or two… or three.

You get them for life.

Everything we publish now… and everything we publish in the future.

What’s more, we’ve managed to keep the price of a lifetime subscription to The Money Map Passport Club well below the $28,000+ it would typically cost to get all our services for just one year.

I’ll go over the pricing details in a moment (including an amazing gift we’ve set aside for you here, exclusively for Money Map staff and brand-new Passport Club members.)

But first, here’s a rundown of what you get:

Everything We Publish, For Life – And More

1) The Capital Wave Forecast

“Capital Waves” refer to big movements of capital in one direction or another that push prices dramatically.

Professional traders use “capital waves” to make huge gains in one fell swoop. Almost anything can spark a “capital wave” and get it moving. An interest rate change… commodity price swings… “head fakes” from “big money” traders to throw competitors off the scent…

And suddenly massive amounts of money are moving in one direction with all the force of a 20-foot ocean wave pushing tons of water before it.

Of course the trick is to be on board just as a capital wave starts to swell. That’s where expert trader and Capital Wave editor Shah Gilani comes in.

Shah is a “trader’s trader.” He’s devoted his entire life to understanding the inner workings of the markets.

And over the years he’s made a ton of money…

• As a young hedge fund manager, he leveraged $10 million into $100 million…
• He founded a fixed-income trading desk that became the dominant player in the $50 billion Unit Investment Trusts (UIT) market…

• When others panicked in October 1987, he secured $100 million from a leading bank and scored a million-dollar windfall on UITs…

• His proprietary currency-trading model has identified gains of 10-20% every month for more than a year…

Subscribers to his Capital Wave Forecast have an opportunity not too many average investors have – the chance to know where the big money is flowing as it’s happening… before it becomes mainstream news and the chance to profit is gone.

It’s led to some nice wins since Shah launched his service – including 165% on a VIX play and 167% on a Euro Proshares play. This year, he’s had 17 straight winning picks for 554% gains – and 23 out of 24 (95.8%) of his closed positions since January are winners.

List Price: $3,500 per year

For Passport Members: FREE

Plus there’s…

2) Global Resource Alert

It’s no secret that resources are on fire of late. Take gold, for instance. It just hit a record high in April of this year.  And silver. Up over 47% this year alone… and more than triple where they were five years ago.

But here’s a question: Have you been along for the ride? Did you catch the big gains in your portfolio?

That’s where our own Peter Krauth comes in.

You see, Peter’s known for having identified a unique “trigger” that tells him exactly when gold prices will be rising. It’s been accurate 100% of the time. Every time this “trigger” goes off, gold prices take off.

A few months ago, Krauth used this “trigger” to alert readers to a price jump in gold.

Within 5 days of his “target” date – gold took off over $71.

And by owning shares in commodity-producing companies – like gold miners – you can leverage any rise in gold for even bigger gains.

Here’s an example. Since 2001, gold’s gone from a low of $255 an ounce, to the current price of around $1,500… a decent gain of about 488%.

But a gold miner like Seabridge Gold… well, in 2001, this company was trading for 26 cents a share. It just recently closed at over $31 a share. That’s an astounding gain of 11,823%.

And it’s not just gold.

Across the board, all commodities are enjoying intense interest from investors.

Think silver, both a precious and an industrial metal… Potash, needed for fertilizer… Molybdenum, needed for steel production… Palladium and platinum, required for automobile manufacturing… Or lithium, the energy source needed to power just about every gadget (and soon most cars) on the planet…

They are all either in orbit, or on the launching pad waiting to take off.

So what’s the next big move?

Well, that’s going to be what’s known as “rare earth” elements. According to Peter, rare earths are likely to hand investors more money than all other commodities combined in the next two years.

Fact is, the Global Resource Alert will give you insight and recommendations every month that will allow you to take advantage of the massive movement of money into gold, natural resources, and now the highly profitable “rare earth” elements.

And you don’t have to wait years for your gains to come. Just this year, in fact, Peter’s helped Global Resource Alert subscribers to gains of 77%, 95%, 57%, 58%, 132% – and he’s currently sitting on 20 winning open positions, with gains as high as 169%.

You’ll also get to “sit in” on up-close-and-personal conversations with the top executives in the field. The men and women whose very presence in a company can turn it profitable.

And you’ll get to hear what these top pros have to say on regular conference calls.

You won’t find this kind of “inside the industry” information in any other research advisory service.

List Price: $2,900 per year

For Passport Members: FREE

You’ll also get one of our longest and best-performing advisories:

3) The New China Trader

No serious investor can ignore China’s impact on the world… the global economy…

And especially the income opportunities that country will no doubt generate in the months and years ahead.

Forget the chatter about whether China’s the place to be or not the place to be – whether it’s overbought or underbought.

The fact of the matter is that China, as a market, is where the United States was as an economy after World War II – growing fast and with plenty of growth potential left.

But what investors need to understand is that it’s not just China and Chinese companies…

It’s the global companies that serve China’s markets… The economies China impacts… The resources that China acquires like never before… And the wave of money that moves in and out of China each and every day.

Our very own Chief Investment Strategist, Keith Fitz-Gerald (who lives part-time in Japan), knows more about making money through China than just about any other man walking the U.S. today.

That’s why you should listen when he says this is one of the best times to be an investor in China ever. And Keith is strongly urging all his readers to take advantage of this opportunity right away.

In fact, Keith is so certain of the money still to be made that he does business in China five to six times a year. He has unprecedented access to business leaders, government officials and traders…

It’s an unprecedented 24-hour-a-day access to the most dynamic market in the world. And no other trading advisory service has ever been able to offer this kind of front-line access to a global market.

That’s how New China Trader has been able to generate a long history of gains, including 1,387% in cumulative gains in 2010.

Plus individual gains over the past few years like these to name a few:

Navios Maritime Holdings – 224%

Yingli Green Energy Holdings – 200%

Yanzhou Coal Mining – 141%

ABB Limited – 138%

Linktone – 233%

Guangshen Rail - 137%

Aluminum Corporation of China – 244%, 741% and 816%

FXI – 63%

China Life – 857%, 709%, 1,366% and 1,805%

Gains like these (and those yet to come) are why The New China Trader is a “must have” for anyone serious about making money in today’s new economic reality.

List Price: $3,900 per year

For Passport Members: FREE

Here’s yet another… something you can use to generate some extraordinary income:

4) The Permanent Wealth Investor

In 2008, while the markets vaporized billions in investors’ money, Permanent Wealth Investor editor Martin Hutchinson was quietly making 49% gains on his money.

That’s right. While millions of people lost half of their nest eggs or more during the crash – Martin was making money.

A lot of it. An estimated 100% shift, from top to bottom.

Of course, Martin was doing what he does best: Using his long-tested strategy for making immediate cash from a select stable of companies paying extraordinarily high yields.

We’re talking annual yields of 10%, 15%, 18% or more.

The highest you’ll find without taking on enormous risk. Many of them on securities that were rising in value at the same time… like the six double-digit gains for 85.9%… 44.5%… 22.6%… 14.8%… 22.7%… and 44%.

All with a low-risk profile.

The secret is Martin’s “Alpha Bulldog” picks – companies with generous yielding dividends, combined with powerful price growth.

These Alpha Bulldogs are uniquely positioned to flourish in both good and bad markets. And they have unbroken records of cash payouts… and often increasing amounts of it.

Increases of 50%… 170%… 900%… even 1,000% over long periods of time are the “gold standard” for Martin’s Alpha Bulldog selections.

Readers who first joined Martin as part of Permanent Wealth Investor had the opportunity to collect $4,201 right off the bat…

And the gains have just kept coming.

All totaled, since the start of this program, readers have had the opportunity to cash in on 27 winners – more than two winners per month on average.

And as I write you today, his Alpha Bulldog portfolio sports 12 out of 15 winners – for 702% cumulative gains (dividends included). Pretty remarkable when you consider just how safe and steady these companies are.

Permanent Wealth Investor is the place to go for the safest, high-growth, high-yielding investments.

List Price: $1,995 per year

For Passport Members: FREE

5) The Merchant Banker Alert

The remarkable success many Money Map readers are enjoying with Merchant Banker Alert is predicated on something you probably already know:

That there really are “two markets” out there: One for the ultra rich… and another for everyone else.

A chart published in a recent report by Merchant Banker Alert’s editor Martin Hutchinson, tells much of the story:

So what is “The Rich Man’s Market” – and how can you access it?

That’s where Martin’s Merchant Banker Alert comes in. In it he points you to the very investments that let the privileged rich rack up as much as 5 times the gains you and I are used to seeing from the “regular” markets.

Now, I should warn you that these are not the kinds of investments you’re likely to find through your typical broker… and a few of them might take some effort on your part to buy…

Believe me, it’s worth any extra effort…

Since issuing his first “Rich Man” recommendation back in September of 2010, closed positions have averaged a 21.83% gains, while the 11 current positions are up a cumulative 203%.

And remember, these are not crazy, risky plays. They’re the safe and steady wealth generators the world’s wealthy elite turn to for reliable year-after-year gains.

As a Money Map Passport Club member, you’ll have access to Martin’s “Rich Man’s Market” for life.

List Price: $4,000 per year

For Passport Members: FREE

6) The Energy Advantage

I talked to you a little about Dr. Kent Moors and his death-grip on what’s happening in the highly profitable world of energy earlier.

Well, Energy Advantage is where the average investor can see tangible gains from his wealth of knowledge about the energy sector… The companies that make it up… The bigwigs who make the rules… And the governments that can change them in an instant.

In fact, having a man as connected as Dr. Moors, who can feed you information on which companies are set to “pop” next, is about as close as you can come to having a true-blue “insider” working for you.

Just look at the straight-up performance highlights from his open Energy Advantage portfolio as of today – 16 recommendations since July 2010… 13 of them profitable… 9 of those up double digits – for a cumulative 366% gain in about 9 months.

And, believe me… he’s just getting started!

List Price: $99 per year

For Passport Members: FREE

You also get our flagship newsletter for life:

7) The Money Map Report

Chances are you’ve seen the newsletter that launched the Money Map franchise, Money Map Report.

You know it’s chock full of global recommendations from our entire team of experts – everything from energy plays… to global retailers… to fast-growing infrastructure plays.

If you’ve been with us a while you may know as well that it’s had a history of substantial profits over the years.

But perhaps none so impressive as perhaps our current open positions – up a cumulative 854% on open picks in our trio of portfolios.

Of course as a Passport member, you will continue to receive Money Map Report free for life.

List Price: $99 per year

For Passport Members: FREE

Plus, you’ll get our newest Premium Advisory Service from Dr. Kent Moors:

8) The Energy Inner Circle

As the Money Map franchise has shown, there are lots of ways to get rich in the world.

But make no mistake about it: The biggest money in this world will ALWAYS be made by those who know how to play the energy markets.

The problem is that 99.9% of media pundits, market analysts, money managers, and investment advisors will never be able to help you win at this game.

That’s because, unlike Dr. Kent Moors, THEY don’t have access to the small “Inner Circle” of power players who control 90% of the world’s energy.

So they’re always late getting into the real, fast-moving money plays that only a handful of people in the world can see coming.

Don’t believe Dr. Moors is a connected player in the global energy industry?

You wouldn’t have any doubts if you’d been standing on the veranda of his vacation home in the Bahamas on May 16, 2010…

That’s when a high-level executive from Chinese oil major Sinopec, Li Hui, asked for Dr. Moors’ advice on how to quietly stake as much as $2 trillion worth of claims in unconventional oil and gas plays in Pennsylvania and Wyoming.

You’d be convinced of his clout with the biggest names in energy if you’d been with him in Poland back in February 2010…

That’s when former Polish President (and Nobel Prize winner) Lech Walesa and he were strategizing about the companies, deals, and technologies that could save Eastern Europe from Russian natural gas domination.

You’d believe that energy’s bigwigs depend on Dr. Moors’ counsel if you’d been able to be with him at England’s Windsor Castle on March 12, 2010…

That’s when he sat down with 26 of the highest-level officials in energy (the “Chatham House Rule” prohibits me from revealing them to you) to hammer out the details of a proposal that’ll change the way oil companies are financed – and open the door to huge gains from the transition.

The instances of Dr. Moors being “a front-row-center participant” in some of the biggest energy discussions go on and on…

And this insight he’ll use to guide his Energy Inner Circle readers to some of the biggest potential gains to be had in the energy sector.

Best of all, you couldn’t have gained free lifetime access to Dr. Moors’ brand-new premium service at a better time than right now, just as he’s ramping up his recommendations.

List Price: $2,999 per year

For Passport Members: FREE

And coming very soon…

9) Money Morning’s Private Briefing

A brand-new multi-media news and information service coming mid-2011 featuring articles, commentary and video interviews and discussions delivered online each and every day.

Just another way we plan to keep you “in the loop” when it comes to global geo- and socio-economic trends that can impact your financial success in the near term, or months down the road.

Regular Money Map Members will pay a nominal monthly fee for access to this service… but as a Passport Club member, it’s yours free for life.

Plus you get…

10) The Geiger Index

Quantitative Analysis (or “Quant” Systems) depend on the most complex mathematical modeling in existence. All of the hubbub you’ve been hearing about “Flash Trading” or “High Frequency Trading” are all variations of this “quant” modeling.

It’s making fortunes for hedge funds and big investment banks like J.P Morgan and Goldman. That’s because the results of this kind of algorithmic trading are astonishing.

And Geiger Index editor Keith Fitz-Gerald, one of the founders of quant trading, is making this available for wealth builders who want to get rich – now sooner than later, just like the investment banks.

He’s taken his 20-plus years of programming and, frankly, he’s enabled those outside of the big banks to have the exact same advantages.

I mentioned Geiger’s incredible two-year track record a little earlier – 20 winners out of 20 plays in 2009… and 14 winners out of 15 picks in 2010. That’s right. Keith hit 34 in a row, with one small 5% loss in 2010.

In other words, it’s a near-unbroken chain of success at 97% since its inception in December 2008… and over 150% gains in 2011 already.

How does he do it? Well, that’s Keith’s secret. But he can tell us it’s based on the same kind of mathematical formulation used to keep the B-2 Bomber in the air – the most complex flying weapon in existence.

The Geiger takes this top-secret sensory technology and transforms it into one of the most powerful market tools ever developed.

List Price: $3,900 per year

For Passport Members: FREE

Plus, you get Keith’s newest service:

11) The MicroQuake Alert

Keith Fitz-Gerald’s newest strategy harnesses cutting-edge mathematical science to laser-focus on one thing:

Making you unbelievably rich by safely extracting extraordinary returns from a miniscule segment of the small- and micro-cap market.

These are NEW gains from a market where you probably aren’t currently invested – and from stocks you’ll probably never hear about.

Until now, trying to cash in on these little-known stocks has been extremely risky. Very little is known about them and there’s very little “coverage” from analysts.

For every one that works out, hundreds fail into oblivion, taking many foolhardy investors down with them.

But with his new strategy, Keith has finally cracked this bastion of mega-profits wide open. He’s found the one, unmistakable sign that consistently separates the mega-profit gems from the garbage – a cryptic “tell” that signals like clockwork BEFORE the big hitters in this obscure niche are about to hit the profit jackpot!

Already, the gains are rolling in. Since he launched his new service in August, he’s closed 10 trades – nine of them winners.

List Price: $2,900 per year

For Passport Members: FREE

As I’ve said, when you add up what you’d pay to get everything here, its $26,292 per year.

But remember, as a Money Map Passport Club member, you won’t pay for another subscription ever again.

Once you pay the one-time membership fee, everything – including everything we publish now and in the future – comes to you automatically.

Based on the services we have now that’s a $52,584 value over two years.

Over five years, it grows to $131,460.

And over 10 years, it’s $262,920.

Yet you’ll get it all for life.

(Remember too, these values don’t take into account future price hikes… or services we’re certain to add in the coming years.)

Plus there’s something else ONLY Passport Club members get.

Quarterly Outlook – Four times a year Money Map editors and contributors Keith, Shah, Martin, Peter and Kent will give you their profitable predictions on the economic, political and geopolitical events that will produce the winners and losers of tomorrow.

It’s an excellent way to get an invaluable “big picture” look at what’s going on in the world (the kind of story the “U.S.-centric” mainstream media tends to ignore) – and specific ways to profit from them.

As a Money Map Passport Club member, the Quarterly Outlook (a $250 value) is free, for life.

There’s something else…

Ongoing Reports and Briefings – Whenever one of our Money Map editors publishes a special report, investment white paper, or sector brief, you’ll receive immediate access to it… before any other subscribers even know it’s been released. And it will automatically be sent to you free of charge, for life.

Now at this point you may be wondering what kind of “one-time fee” will you have to pay to see all this research?

Frankly, that’s always been a tricky thing for us. After all, at the rate we’ve grown and added services in such a short time, it’s been very difficult to assign price – one that’s fair to you and lets us keep our business going.

A One-Time Payment Gets You Everything

But we did come up with what we consider to be a very fair “lifetime pricing” formula, which is simply this:

The 1-year subscription prices of all the services we offer, less 73%.

Based on the $26,292 annual listed cost of the services we offer now – that comes to a one-time payment of $7,049.

But as I mentioned before, we only open the doors to Passport membership once, sometimes twice a year. And when we do, we try to “sweeten the deal” as much as we can.

As an added bonus, we’ll send you a check for $2,475 to “cover your play,” on this incredible little biotech we love… or use any way you want.

Enough for a Thousand Shares

That’s enough to give you somewhere between a 1,000- and 1,500-share stake in the company, should you choose to follow this recommendation.

And forget for a moment about the 150% we’re expecting this year.

Enough to cover the cost of your Passport Club lifetime membership more than 22 times over… put a kid through college… buy yourself a Aston Martin V8 Vantage Roadster… or sock away for a year-long round-the-world adventure when you retire!

And don’t forget all the “big money” that’s already in this company – and what they believe will drive the stock price higher.

There are near-term events that could have a profound impact on the stock price.

Within the next month, the company’s expected to hear another independent review of trial safety data. If positive, it will send yet another signal to the market that one of the biggest roadblocks to FDA approval – product safety – looks not to be an issue with this drug.

Then in October, it’s expected the data from the two current efficacy trials will be released. If positive, look for the stock price to soar, since Phase 3 trials are typically the ones upon which the FDA grants or denies approval.

But make no mistake…

It’s the long term that has investors really excited.

Think about it.

It’s been thirteen years since Viagra stormed onto the drug scene as an answer for sexual impotence in men everywhere. It’s been breaking drug industry sales records ever since… and last year alone racked up over $1.9 million in sales, despite competition from Cialis and other imitators.

Yet there is still no FDA-approved product for the estimated 40 million women suffering from lack of sexual desire and low sexual activity.

Based on highly promising results in Phase 1 and Phase 2 studies, this little company’s could be the first.

Let’s look at some quick numbers so we can get an idea of the market potential for such a drug.

We said an estimated 40 million women suffer from FSD.

Let’s assume 15% of them use the drug on the advice of their physicians.

That’s about 6 million customers.

Assume those women use the drug just one time a week – at the estimated cost of $9 per use…

That’s $2.8 billion in potential sales!

Of course if half of those women use the drug twice a week, those numbers swell to $4.8 billion…

And remember two very important things here…

These numbers only represent potential U.S. sales. Should this company get global approval, sales numbers could quadruple from there!

And unlike Viagra today, there will be no initial competition from other FDA-approved sources.

Once approved, this company’s drug will have the FSD market to itself!

Are you beginning to see the enormous potential this little company has… why so many top players are early-in investors… And why we think the company’s “Female Viagra” will be one of the biggest drug stories of the decade?

That’s why it’s so important you act right away.

You can still get in at a good price – right around $2 a share as I write you today.

But when and if these catalysts start hitting – as early as
June, as our research suggests – you could see a very fast rise in the company’s stock price.

And because stock prices tend to move higher with earnings, there’s no reason why this little company couldn’t be trading in the $ 5.50 as its FSD works its way through Phase 3 trials and closer to FDA approval.

And even higher from there once the drug is introduced to the marketplace in late 2012 according to the company’s estimates – and everyone from the financial press to late-night talk show hosts start talking about it.

Bottom line is this very much looks to be one of those rare situations you can wait a lifetime hoping to find. A young company – virtually undiscovered by the mainstream – but on the cusp of becoming a major player in a very lucrative field.

It’s Happened Many Times Before!

Again, there’s no denying what can happen to a company’s stock price when one of its drugs hits. They can go up and up and up…

Take a look at what MAP Pharmaceuticals’ stock price did over 13 months when just one of their drugs met all endpoints during Phase 3 trials – up 940% in just over 13 months:

That’s why we’re excited to share this opportunity with you and a handful of others who’d like to join our small group. When you sign up for Passport Club, you’ll have instant access to our full report on the company, which we titled The Little Company On The Verge Of Viagra-Sized Gains!

And to show you just how confident we are in our research, we’re offering you $2,475 to take a nice “starting stake” in the little company we believe is the next to take off like these did.

Like I told you earlier, you’re under no obligation to buy shares with the money we send you. Your check will be made out in your name, so you can cash it and do whatever you please with it.

Use some or all of it to buy stock in this company…

Use it to trade any of the number of great opportunities you’re certain to see through your new Passport Club subscriptions.

Use it to take a little vacation… or pay off some bills.

It’s totally up to you.

I’ve Set Aside a Full Day to
Write Out These Checks

Just know that Mike has set aside July 5 to do nothing but write out these checks – and they’ll go out by express delivery the very next day, to arrive at your door within 3 business days, guaranteed.

If you don’t want to wait that long for your check, there’s another option if you choose it.

You can simply take the $2,475 directly off the price of your Passport Club membership – and put that money towards the stock (or whatever you like) right away.

So instead of $7,049, you would pay just $4,574 to activate your membership now (which adds up to a whopping 83% discount off the
one-year price of everything!)

Never before has anyone offered to send you the money by express delivery to buy the stock we’re recommending – or give you such a substantial “on the spot” discount off the price.

Again, let me sum up what you get with your Passport Club membership:

Of course, once you see the sheer scope of the research you’ll be getting from this day forward… have a chance to look at the track record we’ve produced over the years – in good times and bad… and see the huge potential for profits in the months ahead…

Well, something tells me you’ll have no interest in turning in your membership now or any time in the future.

Besides, once a Passport Club member, you really do become part of a very special and very small fraternity.

Greater Access – to Everything

Among the perks – full access to the entire team of Money Map editors, researchers and advisors.

E-mail us directly any time with any questions you have through our members-only website. Although we can’t offer personal financial advice, we can clear up any questions you may have about a recommendation or the strategies we use within a given advisory.

Also, this is a membership that’s truly lifetime – and lives in perpetuity.

That means so long as we’re publishing our research – you, your heirs, your children’s heirs and so on are entitled to all of it, so long as the annual maintenance fee on the membership is paid.

So once you sign on and pay your one-time fee, this truly is a benefit that will pay dividends for literally generations to come.

But there’s one more thing I want to tell you about…

PLUS: One More Special Gift From Me
(It’s Not What You Might Think…)

It’s a special gift I’d like to give you, should you choose to come on board as a lifetime Money Map Passport Club member.

It’s worth about $500 – but it’s not a special report or free subscription you’d typically expect. (As a Passport Club member, after all, you’ll already be getting all of our research for free.)

Rather it’s a piece of technology and it’s all the rage now.

It’s so popular, in fact, that Apple Computer – the company that makes it – won’t let us officially tell you what it is.

Of course I’m sure you’ll quickly figure it out – now that you know the price.

But more importantly, this incredible piece of technology will enable you to follow all of the Passport Club recommendations online, in fact, almost anywhere you are.

We gave these out to new Passport Club members this past January after I’d bought some for the Money Map staff last holiday season and found myself with a few left.

We thought, “Who better than give them to out best and most loyal subscribers.”

Little did we know the response we’d get… we ended up giving away over 750 of them! (Of course, they got an “older” version – but now that the new one’s available, we’ll make sure you’re able to get that one!)

And if this gift doesn’t interest you – or you already have one – I promise that you’ll be an instant hero to anyone you decide to give it to.

Of course this is just a fun little gift – from us to you.
The real benefit of Passport Club membership is the wealth of actionable (and potentially profitable) information you’ll see from this day forward…

Including, of course, the little company with the potential “breakthrough drug” of the decade. The one we think could shoot up 150% this year alone – and maybe pay for a huge chunk of your retirement down the road.

It all adds up to our best Passport Club offer we’ve ever made by far.

How It All Works

The Best Investment Decision
You Can Make

I’m confident that joining Passport Club will be the best investment decision you’ll ever make. The gains we’ve seen in recent months from our line-up of premium advisory services are impressive to say the least:

	The 88% in cumulative gains we’ve seen from Dr. Moors in just six months… on his most conservative plays (and his Energy Inner Circle is just ramping up)…
	The 8 out of 10 winners from MicroQuake when Keith’s new service was introduced this past August…
	Triple-digit winners from Shah and his Capital Wave…
	The 34 out of 35 (a 97% win rate) with 34 consecutive winners that Keith Fitz-Gerald’s Geiger Index has generated since December 2008…
	The 685% gains we’ve enjoyed from Peter’s Global Resource Alert plays in 2010…
	The big gains New China Trader has generated over the years on "emerging economy" plays: 1,805% on China Life… 817% in Aluminum Corporation of China… 233% in Linktone… 104% on Yingli Green Energy Holdings… and the 1,387% cumulative gains we enjoyed in 2010…

And all the gains almost certain to come – including the little drug company with so many of Wall Street’s top money men piling in millions…

The one whose “Female Viagra” could revolutionize the treatment of FSD in the coming years… and reward early-in investors with 50- to 100-fold gains by the time you’re ready to retire (or sooner!)

Plus you’ll learn all about the little company we recommended earlier this year – the one that just gained FDA approval for the shingles pain medicine. Even though the stock nearly doubled in price recently, we think there’s still a lot more money to be made with this little company, as sales start rolling in from its new pain product and as other promising drugs move through its pipeline.

We Suggest You Act on this Quickly

Remember, you have until July 1, 2011 to decide if Passport Club membership is for you. If not, just let us know before then and we’ll refund 100% of what you paid to join.

In fact we’re so confident you’ll love being a member of the Passport Club, you can keep our “Apple Gift”… even if you request a refund!

They’ll give you certified VIP treatment and answer every question you might have.

I have to tell you, I’m excited about this offer.

Never before have we had an opportunity to give you such a unique deal on virtually every resource we offer (or will offer) for life…

Not to mention cover a stake you might choose to take in a company we strongly believe could shoot up 150% this year… and potentially “pay for retirement” over the next two to five years.

I very much look forward to welcoming you personally into our small circle of lifetime Passport Club members.

Sincerely,

Laura Cadden
Associate Publisher, Money Map Press
May 2011

P.S. Remember, we’ll be sending out the "Apple Gifts" I’ve set aside for this offer on a “first-come, first-served” basis. That’s one reason we need to hear from you right away…

More importantly though, we fully expect the first catalyst that will drive our little drug stock higher to come around by mid-June.

That’s why if you’re even considering this opportunity please get in right away, and be sure the check out the special report, The Little Company On The Verge Of Viagra-Sized Gains. The response to our Passport Club “lifetime” offer is strong whenever we extend it, simply because of the value of it alone. But never before have we given away checks and a $500 gift in addition…